Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -57.18% is 68% above its 2-year average of -176.51%, near the high end of its 2-year range (-733.70%–-40.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.51% below its 12-month average of -56.89%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -57.18%.
RETURN ON EQUITY (ROE)
-57.18%
RETURN ON EQUITY (ROE) AVG TTM
-56.89%
RETURN ON EQUITY (ROE) AVG 3Y
-176.51%
RETURN ON EQUITY (ROE) AVG 5Y
-176.51%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.51%
CURRENT VS 3Y AVG
+67.60%
CURRENT VS 5Y AVG
+67.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-539.53%
vs the sector median at left
Tempus AI, Inc.
Market Cap
$10.74B
Return on Equity (ROE)
-57.18%
TTM Avg
-56.89%
3Y Avg
-176.51%
5Y Avg
-176.51%
Market Cap
$10.64B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$10.95B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$11.31B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$10.15B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$10.13B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.05B
Return on Equity (ROE)
11.23%
TTM Avg
7.12%
3Y Avg
6.90%
5Y Avg
7.16%
Market Cap
$10.02B
Return on Equity (ROE)
12.77%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.01B
Return on Equity (ROE)
15.51%
TTM Avg
15.81%
3Y Avg
15.92%
5Y Avg
17.27%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $10.74B | -57.18% | -56.89% | -176.51% | -176.51% |
| Universal Health Services, Inc. (UHS)vs › | $10.64B | 20.31% | 18.80% | 15.17% | 15.31% |
| Align Technology, Inc. (ALGN)vs › | $10.95B | 9.77% | 10.54% | 10.84% | 19.93% |
| Bio-Techne Corporation (TECH)vs › | $11.31B | 8.63% | 6.23% | 8.78% | 10.01% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.15B | 3.10% | -8.94% | -15.72% | 1.14% |
| Molina Healthcare, Inc. (MOH)vs › | $10.13B | -0.17% | 18.91% | 22.60% | 24.60% |
| Globus Medical, Inc. (GMED)vs › | $10.05B | 11.23% | 7.12% | 6.90% | 7.16% |
| Henry Schein, Inc. (HSIC)vs › | $10.02B | 12.77% | 11.88% | 12.69% | 13.50% |
| The Ensign Group, Inc. (ENSG)vs › | $10.01B | 15.51% | 15.81% | 15.92% | 17.27% |
| DaVita Inc. (DVA)vs › | $11.75B | N/A | 329.18% | 200.63% | 164.66% |
ROE
-57.2%
ROA
-10.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -57.18% |
| 2026-03-31 | -72.74% |
| 2025-12-31 | -49.87% |
| 2025-09-30 | -40.15% |
| 2025-06-30 | -64.52% |
| 2025-03-31 | -217.39% |
| 2024-06-30 | -733.70% |
| 2021-03-31 | -102.59% |
